Unlocking the predictive power of imaging biomarkers: predicting immune checkpoint therapy response in non-small cell lung cancer through baseline tumour vessel perfusions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unlocking the predictive power of imaging biomarkers: predicting immune checkpoint therapy response in non-small cell lung cancer through baseline tumour vessel perfusions

Published:2024-08 Issue:1 Volume:3 Page:e000539
ISSN:2752-7948
Container-title:BMJ Oncology
language:en
Short-container-title:bmjonc

Author:

Dubash Suraiya^ORCID,Tsang Yat^ORCID

Publisher

BMJ

Reference6 articles.

1. Predictive Biomarkers for Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: current Status and Future Directions;Bhalla;Cancer J,2020

2. Liu Z , Ma K , Jia Q , et al . Baseline tumor vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer. BMJ Oncol 2024. doi:10.1136/bmjonc-2024-000473

3. PD-L1 as a biomarker of response to immune-checkpoint inhibitors;Doroshow;Nat Rev Clin Oncol,2021

4. T cell dysfunction and therapeutic intervention in cancer;Zebley;Nat Immunol,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP